Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04995172 · ClinicalTrials.gov registry record
Feasibility of Mobile-CT-Assisted Bronchoscopy for the Diagnosis of Lung Lesion
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 72
- Enrollment target
NCT04995172: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT04995172 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04995172 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
This study investigates whether using a mobile-CT-assisted bronchoscopy (M-CAB) during a bronchoscopy procedure will better enable the study staff to reach the lung tumor, perform a biopsy, and obtain a diagnosis. One method that doctors use for diagnosing lung tumors is bronchoscopy guided by an X-ray machine (called fluoroscope). Though much better guidance could be provided with a CT scanner when compared to the fluoroscope, the standard CT equipment is very large, fixed in a radiology room, and difficult to use with bronchoscopy. Mobile CT imaging systems may more easily and effectively perform the same tasks of the standard CT imaging in the bronchoscopy room, offering better guidance than the standard fluoroscope.
Primary Outcome
Defined as the proportion of patients in whom bronchoscopy with thin or ultrathin scope, radial-probe endobronchial ultrasound (RP-EBUS) and 2-dimensional (2-D) fluoroscopy is non-diagnostic (lesion is not reached or rapid-onsite cytology is non-diagnostic) and diagnosis is obtained after utilizing mobile-CT assistance. Descriptive statistics (mean standard deviation \[SD\] or median interquartile range \[IQR\], frequency \[%\]) will be used to summarize patient characteristics.
Interventions
- PROCEDURE Computed Tomography
- OTHER Electronic Health Record Review
- PROCEDURE Endobronchial Ultrasound Bronchoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2024-11-27 |
What the finished NCT04995172 record still lists
NCT04995172 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Computed Tomography is the first listed.
NCT04995172 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04995172 about?
NCT04995172 is a clinical study titled "Feasibility of Mobile-CT-Assisted Bronchoscopy for the Diagnosis of Lung Lesion". This study investigates whether using a mobile-CT-assisted bronchoscopy (M-CAB) during a bronchoscopy procedure will better enable the study staff to reach the lung tumor, perform a biopsy, and obtain a diagnosis. One method that doctors use for diagnosing lung tumors is bronchoscopy guided by an X-...
What is the current status of trial NCT04995172?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2021-04-19. Estimated completion is 2024-11-27.
What interventions are being tested in trial NCT04995172?
The interventions under investigation include: Computed Tomography (PROCEDURE), Electronic Health Record Review (OTHER), Endobronchial Ultrasound Bronchoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT04995172?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI